Yunjoon Kim (金延埈)
Managing Director at Korea Investment Partners- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Korea Investment Partners
-
South Korea
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Managing Director
-
Jan 2019 - Present
- Successful IPO portfolios : SCM Lifescience (Cell Therapy : KOSDAQ), ABL bio ( Immuno-oncology : KOSDAQ ), Genome & Company (Microbiome - KONEX ), Eloxx Pharmaceuticals (Orphan disease - NASDAQ)
-
-
Investment Director
-
Dec 2015 - Present
- To find and invest in start-ups or entrepreneurs who have high potential for bio healthcare pharmaceutical companies : Key operational personnel at Global Pharmaceutical PE Fund in Korea (fund size 120mUSD)- Perform financial analysis; evaluate a company or idea in terms of its potential and acceptance in the market. Measure the potential hazards and risks involved, and finalize a deal.
-
-
Senior Principal / Venture Capitalist
-
Apr 2014 - Present
-To find and invest in start-ups or entrepreneurs who have high potential for bio / pharmaceutical company- Perform financial analysis, evaluate a company or idea in terms of its potential and acceptance in the market. and measure the potential hazards and risks involved, and finalize a deal. - Area of Interest : Drug Development ( including Biologics, Chemical, Natural Medicine), Medical Technology, Medical Engineering Technology, Medical Devices and etc.
-
-
-
-
Senior Researcher
-
Mar 2013 - Dec 2013
working at Health Technology Transfer Center (: medical technology, pharmaceutical technology, medical engineering technology, food technology, cosmetic technology, etc.) ● Technology Transfer & Licensing ● Technology evaluation & Market assessment ● Technology commercialization ● Facilitates the funding opportunities for biotechnology venture companies ● Assist global collaboration partnership working at Health Technology Transfer Center (: medical technology, pharmaceutical technology, medical engineering technology, food technology, cosmetic technology, etc.) ● Technology Transfer & Licensing ● Technology evaluation & Market assessment ● Technology commercialization ● Facilitates the funding opportunities for biotechnology venture companies ● Assist global collaboration partnership
-
-
-
-
Search & Evaluation Manager
-
Dec 2010 - Feb 2013
● Search for external opportunities which meet Novartis Portfolio strategy ● Evaluate the scientific and commercial opportunities
-
-
Research Alliance Officer
-
Dec 2008 - Dec 2010
● Identify opportunities to strengthen Novartis research presence in Korea● Identify & Liaise the new investment opportunity under the venture fund activities
-
-
-
-
Medical Scientific Liaison Officer
-
2007 - 2008
● Collect, analyze and report insights that may impact Novartis development plans /trial designs. and provide & discuss scientific information and data to healthcare professionals to ensure quality and accuracy of medical and scientific information on new treatment options including Novartis products and selected areas of therapeutic interest. ● Contribute to the identification of appropriate clinical investigators and facilitates placement into Novartis sponsored clinical trials. and support the investigational sites, as needed , as part of a cross-functional team with ICRO and the Medical Advisor and others as appropriate. ● Identify clinical investigators with research proposals that are consistent with our product development strategies and facilitate the Investigator-Initiated Research Protocol (IIRP) process including study completion, presentation, and publication, as appropriate. ● Provide medical support and training (i.e. disease state and product) to Novartis colleagues (e.g. sales reps, CRAs, etc.). Show less
-
-
-
-
Professional Medical Representative / Clinical Research Associate
-
2003 - 2006
Diverse experience in Sales, Medical Department. Diverse experience in Sales, Medical Department.
-
-
Education
-
Sungkyunkwan University
Doctor of Philosophy (Ph.D.) at Pharmacy, Pharmaceutical Management of Technology